Latest Financials News

Guzman y Gomez (GYG) has reported record FY25 results, surpassing $1.18 billion in global network sales and delivering a 45.5% increase in EBITDA. The company also declared its maiden fully-franked dividend, signaling confidence in sustained growth.

Inghams Group reported a stable underlying EBITDA of $236.4 million for FY25 despite softer market conditions and customer changes, while guiding for a modest earnings dip in FY26 as cost reduction programs take effect.

Guzman y Gomez (GYG) has reported a record FY25 with $1.2 billion in network sales and a 152% jump in net profit, underpinned by strong comp sales growth and rapid restaurant expansion. The company also declared its first dividend and outlined ambitious plans for continued growth and margin improvement.

Boom Logistics has reported a robust FY25 performance, with a 38% increase in operating earnings per share, underpinned by strong renewables and transmission projects despite challenges in resources and infrastructure.

Inghams Group Limited reported a 3.4% revenue decline and an 11.5% drop in net profit for FY25, impacted by a new Woolworths supply agreement and lease accounting changes, while maintaining stable underlying earnings and declaring an 8-cent fully franked final dividend.

Webjet Group has acquired Locomote to fast-track its business travel offering, aiming for significant growth by FY30, while also launching a $25 million share buy-back program to return capital to shareholders.

Credit Clear Limited reported a strong FY25 with 12% revenue growth and a 76% jump in underlying EBITDA, driven by digital innovation and client expansion. The company sets an ambitious FY26 outlook alongside a new share buy-back program.

Guzman Y Gomez Limited has announced a fully franked ordinary dividend of AUD 0.126 per share for the financial year ending June 2025, signaling steady shareholder returns.

Zip Co Limited’s FY25 results reveal a powerful US market expansion driving a 147% rise in cash earnings and a strategic Nasdaq dual listing consideration.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

Guzman y Gomez Limited (GYG) reported a strong FY25 turnaround with revenue up 27% and a maiden fully franked dividend declared, underpinned by robust Australia segment growth and ongoing US expansion.

Zip Co has delivered a standout FY25 with cash earnings soaring 147%, driven by rapid US market expansion. The company is now considering a Nasdaq dual listing to fuel further growth.